Picard Medical, Inc. (PMI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Picard Medical, Inc. on December 9, 2025. The company is incorporated in Delaware and operates as an emerging growth company. Its common stock trades on the NYSE American under the symbol PMI. The filing primarily serves to disclose a material update regarding the company's SynCardia Total Artificial Heart.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
There are no reported material changes to financial performance or operational status in this document. The sole material event is the issuance of a press release (Exhibit 99.1) providing an update on the SynCardia Total Artificial Heart.
Guidance, Outlook, and Risks
The filing references a press release containing an update on the SynCardia Total Artificial Heart but does not include the text of that release, specific guidance, or detailed risk factors within the body of this 8-K. The document explicitly states that the information contained herein is not deemed "filed" for purposes of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (the Press Release dated December 9, 2025) for specific details on the SynCardia Total Artificial Heart update.
- Verify the company's status as an emerging growth company and its implications for financial reporting standards.
- Confirm the trading status of PMI on the NYSE American.
- Note that this 8-K does not contain audited financial figures; refer to the most recent 10-K or 10-Q for financial health metrics.